← Leaderboards
Doris Kretzschmar
Oregon Health And Science University
$7,049,005
Attributed
$8,074,823
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,074,823 · 8
By mechanism
R01$4,329,940 · 3
RF1$1,523,646 · 1
U19$996,115 · 1
R21$847,000 · 2
R56$378,122 · 1
Top collaborators
- Jadwiga M Giebultowicz7 shared
- Svetlana Nikolaevna Radyuk6 shared
Most similar at Oregon Health And Science University
Same institution · by research overlap
- Jau-Shin Lou$1,389,037
- Joseph F Quinn$13,031,665
- David B Morton$4,780,828
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectNeuronsIn VivoInsightPathway InteractionsMolecularDrosophila GenusMutantBrainGene ExpressionGenesMutationNerve DegenerationLeadPlayAgingTransgenic OrganismsAge RelatedRegulationPreventProteinsDrosophila MelanogasterHeadMammals
Grant awards (29)
Connecting nuclear functions of Tau with pathology in Alzheimer's disease and other Tauopathies$390,000
R01 · FY2024 · AG · contact PI
Mechanism based evaluation of botanical bioactive compounds enhancing neurological resilience (Project 2)$155,268
U19 · FY2024 · AT · contact PI
Mechanism based evaluation of botanical bioactive compounds enhancing neurological resilience (Project 2)$157,302
U19 · FY2023 · AT · contact PI
Mechanism based evaluation of botanical bioactive compounds enhancing neurological resilience (Project 2)$301,386
U19 · FY2022 · AT · contact PI
Mechanism based evaluation of botanical bioactive compounds enhancing neurological resilience (Project 2)$195,303
U19 · FY2021 · AT · contact PI
Mechanism based evaluation of botanical bioactive compounds enhancing neurological resilience (Project 2)$5,664
U19 · FY2021 · AT · contact PI
Connecting nuclear functions of Tau with pathology in Alzheimer's disease and other Tauopathies$1,523,646
RF1 · FY2020 · AG · contact PI
Mechanism based evaluation of botanical bioactive compounds enhancing neurological resilience (Project 2)$181,192
U19 · FY2020 · AT · contact PI
Links between age-related changes in energy metabolism and Alzheimer's disease.$378,122
R56 · FY2019 · AG
Connecting Alzheimers Disease, APP, Circadian Regulation$192,500
R21 · FY2019 · AG · contact PI
Connecting Alzheimers Disease, APP, Circadian Regulation$231,000
R21 · FY2018 · AG · contact PI
Circadian Clocks and Aging$252,931
R01 · FY2017 · AG
Creating new Drosophila models to study Tau loss and gain-off functions$192,500
R21 · FY2017 · NS · contact PI
Circadian Clocks and Aging$253,238
R01 · FY2016 · AG
Creating new Drosophila models to study Tau loss and gain-off functions$231,000
R21 · FY2016 · NS · contact PI
Circadian Clocks and Aging$10,255
R01 · FY2016 · AG
Circadian Clocks and Aging$235,939
R01 · FY2015 · AG
Circadian Clocks and Aging$243,504
R01 · FY2014 · AG
SWS/NTE function in neurodegeneration and axonopathy$318,583
R01 · FY2013 · NS · contact PI
Circadian Clocks and Aging$259,268
R01 · FY2013 · AG
SWS/NTE function in neurodegeneration and axonopathy$330,138
R01 · FY2012 · NS · contact PI
SWS/NTE function in neurodegeneration and axonopathy$330,138
R01 · FY2011 · NS · contact PI
SWS/NTE function in neurodegeneration and axonopathy$333,507
R01 · FY2010 · NS · contact PI
SWS/NTE function in neurodegeneration and axonopathy$336,875
R01 · FY2009 · NS · contact PI
SWS/NTE function in neurodegeneration and axonopathy$231,765
R01 · FY2007 · NS · contact PI
SWS/NTE function in neurodegeneration and axonopathy$238,687
R01 · FY2006 · NS · contact PI
SWS/NTE function in neurodegeneration and axonopathy$244,431
R01 · FY2005 · NS
SWS/NTE function in neurodegeneration and axonopathy$76,250
R01 · FY2005 · NS
SWS/NTE function in neurodegeneration and axonopathy$244,431
R01 · FY2004 · NS